Eydenzelt – a biosimilar referencing Eylea (aflibercept) – has been approved in the United States market for a range of neovascular retinal conditions.

Researchers in Japan have developed a novel mRNA vaccine that, when delivered via intramuscular injection, significantly suppresses abnormal blood vessel growth in the retina,

The Cornea and Contact Lens Society of Australia is hosting a face-to-face evening dinner event on keratoconus – discussing what’s new, what to watch

Two new white papers from the International Myopia Institute (IMI) have been published, providing the global eye care community with the latest evidence-based insights